Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Deferoxamine may help protect inner ear cells from damage caused by oxidative stress.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Minoxidil is more effective than Latanoprost for treating patchy alopecia areata.

Chronic contact eczema may help hair regrowth in alopecia areata by reducing certain immune cell movement.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

UV light helped human hair transplants survive in mice without broad immunosuppression.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Ebastine may help regrow hair in alopecia areata patients.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.